Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Patients with neuromuscular disorder.
The rehabilitation of the multiple sclerosis patient.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
"Optic neuritis" that is neither.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
The Evaluation of Multiple Sclerosis Dispersal in Iran and Its Association with Urbanization, Life Style and Industry.
Differential Regulation of CD4+ T Cell Adhesion to Cerebral Microvascular Endothelium by the β-Chemokines CCL2 and CCL3.
Distinct and Atypical Intrinsic and Extrinsic Cell Death Pathways between Photoreceptor Cell Types upon Specific Ablation of Ranbp2 in Cone Photoreceptors.
Diagnostic modalities in multiple sclerosis: Perspectives in children.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature.
Multiple sclerosis treatment: risk mitigation.
Multiple sclerosis: Disease activity is reduced in CIS after BCG vaccination.
Mesenchymal stem cells: A new diagnostic tool?
Levels of mRNA for dopaminergic receptor D5 in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.

Pages